We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Clinical Chemistry Analyzer Offers Increased Efficiency and Productivity

By LabMedica International staff writers
Posted on 02 Mar 2011
The latest addition to a series of clinical chemical analyzers provides increased efficiency and productivity. More...


The RX series of four clinical chemistry analyzers provide quality results at every phase of clinical development. The analyzers offer an extensive test menu enabling laboratories to avoid the costly outsourcing of routine safety testing.

The latest addition to the series is the RX suzuka, a fully automated random access analyzer capable of carrying out up to 1200 tests per hour including ISEs. The RX monza is the smallest of the series; it is a semi- automated clinical analyzer ideal for low throughput testing in clinical, research laboratories, and specialized clinics. The RX daytona is a compact benchtop fully automated clinical analyzer with a throughput of 180 photometric tests and 270 ISE tests per hour. The RX imola is a fully automated and random access benchtop analyzer capable of performing 400 photometric tests and 240 ISE tests per hour.

Each system requires only a small sample volume. Reagent volume required is also low, reducing cost per test. The RX Series require no extra consumables--for example, permanent pyrex cuvettes are used, providing considerable cost savings.

Randox Pharma Services ( Crumlin , UK) markets the RX series of analyzers. The company also offers an extensive test menu consisting of over 120 enzymatic, substrate, and immunoturbidimetric assays.

In addition to the analyzers, a Quality Control (QC) package is provided. Randox quality controls cover over 170 parameters and are of high quality, accurate, and stable ensuring valid clinical results. Customized QC is also available in addition to RIQAS, the largest global EQA scheme.

Related Links:

Randox Pharma Services





Gold Member
Aspiration System
VACUSAFE
Online QC Software
Acusera 24•7
All-in-One Molecular System
AIO M160
Manual Pipetting Aid
Pipette Controllers macro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Microbiology

view channel
Image: The study compares rapid molecular CPE diagnostics, which can return results in about one hour, with culture-based screening, which typically takes about 48 hours (Image credit: Adobe Stock)

Rapid Molecular Screening Aims to Accelerate Hospital Infection Control for CPE

Drug-resistant infections remain a critical patient-safety threat in hospitals, with carbapenemase-producing Enterobacterales (CPE) among the most urgent concerns. In England, reports of acquired carbapenemase... Read more

Pathology

view channel
Image: The VENTANA PTEN (SP218) RxDx Assay is a qualitative IHC assay for assessing PTEN protein in prostate adenocarcinoma, with staining performed using the OptiView DAB IHC Detection Kit on a BenchMark ULTRA instrument (Photo courtesy of Roche)

New Companion Diagnostic Expands Precision Medicine in Prostate Cancer

Prostate cancer is a leading cancer diagnosis in men and becomes particularly aggressive when it presents as metastatic, hormone-sensitive disease. Tumors with loss of phosphatase and tensin homolog (PTEN)... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.